Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Caredda

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1984
Acute type B hepatitis in parenteral drug-addicts (PDA): prognostic value of circulating HBsAg/IgM complexesF Caredda, R De Franchis, A D'Arminio Monforte, et al.
Progress in Clinical and Biological Research|January 1, 1983
Epidemiological and clinical features of fulminant delta hepatitisA Smedile, G Saracco, F Caredda, et al.
Journal of Hepatology|December 1, 1987
Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infectionG Saracco, F Rosina, M R Brunetto, et al.
Lancet (London, England)|February 28, 1987
Serological response to the hepatitis delta virus in hepatitis DM Aragona, S Macagno, F Caredda, et al.
Lancet (London, England)|August 17, 1985
Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriersS Arico, M Aragona, M Rizzetto, et al.
Journal of Hepatology|January 1, 1990
Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre studyG Realdi, G Fattovich, G Pastore, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1984
The aetiology of acute hepatitis in ZimbabweP R Crocchiolo, F Caredda, A D'Arminio Monforte, et al.
Infection|May 1, 1985
Attempted treatment of fulminant viral hepatitis with human fibroblast interferonF Milazzo, M Galli, P G Fassio, et al.
Lancet (London, England)|October 30, 1982
Influence of delta infection on severity of hepatitis BA Smedile, P Farci, G Verme, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1984
Acute type B hepatitis in parenteral drug-addicts (PDA): prognostic value of circulating HBsAg/IgM complexesF Caredda, R De Franchis, A D'Arminio Monforte, et al.
Progress in Clinical and Biological Research|January 1, 1983
Epidemiological and clinical features of fulminant delta hepatitisA Smedile, G Saracco, F Caredda, et al.
Journal of Hepatology|December 1, 1987
Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infectionG Saracco, F Rosina, M R Brunetto, et al.
Lancet (London, England)|February 28, 1987
Serological response to the hepatitis delta virus in hepatitis DM Aragona, S Macagno, F Caredda, et al.
Lancet (London, England)|August 17, 1985
Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriersS Arico, M Aragona, M Rizzetto, et al.
Journal of Hepatology|January 1, 1990
Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre studyG Realdi, G Fattovich, G Pastore, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1984
The aetiology of acute hepatitis in ZimbabweP R Crocchiolo, F Caredda, A D'Arminio Monforte, et al.
Infection|May 1, 1985
Attempted treatment of fulminant viral hepatitis with human fibroblast interferonF Milazzo, M Galli, P G Fassio, et al.
Lancet (London, England)|October 30, 1982
Influence of delta infection on severity of hepatitis BA Smedile, P Farci, G Verme, et al.
Pageof 5